Skip to content
AnalystLens

Rocket Lab 8-K Report, Material Agreement (Feb 7, 2024)

Reports
Material Agreements·Financial Events·Securities & Listing+2
Filing Date
Filed February 7, 2024
Period End
February 1, 2024
Security
RKLB
In the record · 2020–202610-K810-Q188-K88

RKLB filed 8 annual reports (10-K), 18 quarterly reports (10-Q) and 88 current reports (8-K) between 2020 and 2026.

  1. Deal closed8-K · Jan ’22Jan ’22
  2. Material agreement8-K · May ’23May ’23
  3. Material agreement8-K · Jun ’26Jun ’26

Summary

Summary of the 8-K filed February 7, 2024. Cited figures are marked; the original filing is the authoritative source.

On February 6, 2024, Rocket Lab USA issued $355.0 milliona of 4.250% Convertible Senior Notes due February 1, 2029, after upsizing the offering from $300.0 million and fully exercising the $55.0 million option granted to the initial purchasers.

The notes are senior, unsecured obligations. They are effectively subordinated to the company's secured debt, including its equipment financing agreement, and structurally subordinated to all liabilities of its subsidiaries. Interest is payable semi-annually beginning August 1, 2024.

The initial conversion price is approximately $5.13b per share (195.1029 shares per $1,000 principal), and conversion may be settled in cash, shares, or a combination at the company's election. Holders can convert before November 1, 2028 only upon certain triggering events, and freely thereafter. The company entered into capped call transactions at a cost of about $43.2 million to offset dilution from conversions up to a cap price, which management says lifts the effective conversion price to $8.04.

Per the press release, net proceeds are about $300.3 millionc after capped call costs and roughly $11.5 million of underwriting and offering expenses. About $40 million is earmarked to repay part of the equipment financing borrowings, with the remainder for working capital and general corporate purposes, including potential acquisitions. Management cited oversubscription and the comparatively low cost of capital and reduced dilution relative to equity issuance as rationale.

Investors should weigh the near-term balance sheet benefit against the coupon of roughly $15 milliond per year, the dilution risk if the stock trades well above the cap price, and the limited call protection before February 2027. The filing also specifies that the company may not redeem the notes before February 1, 2027. After that date, redemption requires a share price above 130% of the conversion price (about $6.67) for specified trading periods, plus liquidity conditions.

Holders may require repurchase at par plus accrued interest upon a fundamental change, and standard events of default apply, including a cross-default threshold of $50 million on other indebtedness. Notes were sold under Rule 144A, and any conversion shares are to be issued under Section 3(a)(9), with an initial maximum of about 88.3 million shares at the make-whole maximum conversion rate.

Key Highlights

  1. Issued $355.0 million of 4.250% convertible senior notes due 2029, including the full $55.0 million over-allotment option, after the offering was upsized from $300.0 million due to oversubscription.
  2. Initial conversion price of approximately $5.13 per share; capped call transactions costing about $43.2 million raise the effective conversion price to $8.04.
  3. Net proceeds of about $300.3 million, with approximately $40 million earmarked to repay part of the equipment financing borrowings and the balance for working capital, M&A, and growth investments.
  4. Notes are effectively subordinated to secured debt and structurally subordinated to subsidiary liabilities, which matters for credit-focused investors.
  5. No optional redemption before February 1, 2027; thereafter, redemption requires the stock to trade above 130% of the conversion price along with liquidity conditions.
  6. Initial maximum of about 88.3 million shares could be issued on conversion at the make-whole maximum rate, creating potential dilution beyond the capped call protection.
  7. Standard covenants and events of default include a $50 million cross-default threshold on other indebtedness and bankruptcy-related acceleration.

Frequently Asked Questions

  1. What is the cost of the debt and when does it come due?

    The notes carry a 4.250% fixed coupon, paid semi-annually on February 1 and August 1, starting August 1, 2024. Annual interest is roughly $15 million on the $355 million principal. The notes mature on February 1, 2029, unless converted, redeemed, or repurchased earlier.

  2. How could the notes dilute existing shareholders?

    Conversion at the initial rate would result in about 69 million shares at $5.13, and the make-whole maximum rate implies up to about 88.3 million shares. The capped call transactions are designed to offset dilution up to the cap price. Above that price, dilution still occurs to the extent the stock exceeds the cap. The company may also settle conversions in cash, which limits share issuance.

  3. When can the company force conversion or redeem the notes?

    The company cannot redeem the notes before February 1, 2027. After that, it may redeem if the stock has closed above 130% of the conversion price (about $6.67) on at least 20 of 30 consecutive trading days and other conditions are met. Calling a note triggers a make-whole adjustment that can increase the conversion rate for holders who convert after the call.

  4. What happens to noteholders if the company is acquired or delisted?

    Certain fundamental change events, including business combinations, stockholder approval of liquidation or dissolution, and certain delisting events, allow holders to require repurchase at par plus accrued interest. Make-whole adjustments may also increase the conversion rate in qualifying corporate transactions.

  5. How will the company use the proceeds, and what does that mean for the balance sheet?

    About $40 million will repay part of the equipment financing borrowings, which reduces secured debt. The remainder is for working capital and general corporate purposes, including potential acquisitions and strategic investments. Management characterized the financing as a low-cost, less dilutive way to fund growth compared with equity.